BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

858 related articles for article (PubMed ID: 12661753)

  • 21. High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: results of two randomized, placebo-controlled, multicenter studies.
    Spruance SL; Jones TM; Blatter MM; Vargas-Cortes M; Barber J; Hill J; Goldstein D; Schultz M
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1072-80. PubMed ID: 12604544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Open-label study of valacyclovir 1.5 g twice daily for the treatment of uncomplicated herpes zoster in immunocompetent patients 18 years of age or older.
    Madkan VK; Arora A; Babb-Tarbox M; Aboutlabeti S; Tyring S
    J Cutan Med Surg; 2007; 11(3):89-98. PubMed ID: 17511925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
    Tyring SK; Baker D; Snowden W
    J Infect Dis; 2002 Oct; 186 Suppl 1():S40-6. PubMed ID: 12353186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Valacyclovir for the suppression of recurrent genital herpes in human immunodeficiency virus-infected subjects.
    DeJesus E; Wald A; Warren T; Schacker TW; Trottier S; Shahmanesh M; Hill JL; Brennan CA;
    J Infect Dis; 2003 Oct; 188(7):1009-16. PubMed ID: 14513421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of recurrent oral herpes simplex infections.
    Woo SB; Challacombe SJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103 Suppl():S12.e1-18. PubMed ID: 17379150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind study comparing 2 dosages of valacyclovir hydrochloride for the treatment of uncomplicated herpes zoster in immunocompromised patients 18 years of age and older.
    Arora A; Mendoza N; Brantley J; Yates B; Dix L; Tyring S
    J Infect Dis; 2008 May; 197(9):1289-95. PubMed ID: 18422441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral antivirals for the acute treatment of recurrent herpes labialis.
    Jensen LA; Hoehns JD; Squires CL
    Ann Pharmacother; 2004 Apr; 38(4):705-9. PubMed ID: 14966254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
    Zuckerman RA; Lucchetti A; Whittington WL; Sanchez J; Coombs RW; Zuñiga R; Magaret AS; Wald A; Corey L; Celum C
    J Infect Dis; 2007 Nov; 196(10):1500-8. PubMed ID: 18008230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, double-blind, placebo-controlled trial of valacyclovir prophylaxis to prevent zoster recurrence from months 4 to 24 after BMT.
    Klein A; Miller KB; Sprague K; DesJardin JA; Snydman DR
    Bone Marrow Transplant; 2011 Feb; 46(2):294-9. PubMed ID: 20421867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Valacyclovir therapy to reduce recurrent genital herpes in pregnant women.
    Andrews WW; Kimberlin DF; Whitley R; Cliver S; Ramsey PS; Deeter R
    Am J Obstet Gynecol; 2006 Mar; 194(3):774-81. PubMed ID: 16522412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative bioavailability of acyclovir from oral valacyclovir and acyclovir in patients treated for recurrent genital herpes simplex virus infection.
    Bras AP; Sitar DS; Aoki FY
    Can J Clin Pharmacol; 2001; 8(4):207-11. PubMed ID: 11743593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No effect of antiviral (valacyclovir) treatment in fibromyalgia: a double blind, randomized study.
    Kendall SA; Schaadt ML; Graff LB; Wittrup I; Malmskov H; Krogsgaard K; Bartels EM; Bliddal H; Danneskiold-Samsøe B
    J Rheumatol; 2004 Apr; 31(4):783-4. PubMed ID: 15088307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic effect of 1,5-pentanediol for herpes simplex labialis: a randomized, double-blind, placebo-controlled clinical trial.
    Busch R; Graubaum HJ; Gruenwald J; Faergemann J
    Adv Ther; 2009 Jul; 26(7):719-27. PubMed ID: 19649583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
    Gupta R; Wald A; Krantz E; Selke S; Warren T; Vargas-Cortes M; Miller G; Corey L
    J Infect Dis; 2004 Oct; 190(8):1374-81. PubMed ID: 15378428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding.
    Wald A; Selke S; Warren T; Aoki FY; Sacks S; Diaz-Mitoma F; Corey L
    Sex Transm Dis; 2006 Sep; 33(9):529-33. PubMed ID: 16540883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valacyclovir versus acyclovir for HSV prophylaxisin neutropenic patients.
    Warkentin DI; Epstein JB; Campbell LM; Yip JG; Cox VC; Ransier A; Barnett MJ; Marra F
    Ann Pharmacother; 2002 Oct; 36(10):1525-31. PubMed ID: 12243600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group.
    Spruance SL; Tyring SK; DeGregorio B; Miller C; Beutner K
    Arch Intern Med; 1996 Aug 12-26; 156(15):1729-35. PubMed ID: 8694673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.
    Lowance D; Neumayer HH; Legendre CM; Squifflet JP; Kovarik J; Brennan PJ; Norman D; Mendez R; Keating MR; Coggon GL; Crisp A; Lee IC
    N Engl J Med; 1999 May; 340(19):1462-70. PubMed ID: 10320384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial.
    Rooney JF; Straus SE; Mannix ML; Wohlenberg CR; Alling DW; Dumois JA; Notkins AL
    Ann Intern Med; 1993 Feb; 118(4):268-72. PubMed ID: 8380540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group.
    Patel R; Bodsworth NJ; Woolley P; Peters B; Vejlsgaard G; Saari S; Gibb A; Robinson J
    Genitourin Med; 1997 Apr; 73(2):105-9. PubMed ID: 9215091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.